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Loss of IGF1R in Human Astrocytes Alters Complex I Activity and
Support for Neurons
Laura E. Ratcliffe, Irina Va´zquez Villasen˜or, Luke Jennings, Paul R. Heath, Heather Mortiboys, Aurelie Schwartzentruber,
Evangelia Karyka, Julie E. Simpson, Paul G. Ince, Claire J. Garwood *y and Stephen B. Wharton y
Sheffield Institute for Translational Neuroscience, University of Sheffield, 385A Glossop Road, Sheffield S10 2HQ, UK
Abstract—The insulin/insulin-like growth factor 1 (IGF1) signaling pathways are implicated in longevity and in pro-
gression of Alzheimer’s disease. Previously, we showed that insulin-like growth factor 1 receptor (IGF1R) and
downstream signaling transcripts are reduced in astrocytes in human brain with progression of Alzheimer’s neu-
ropathology and developed a model of IGF1 signaling impairment in human astrocytes using an IGF1R-specific
monoclonal antibody, MAB391. Here, we have established a novel human astrocyte-neuron co-culture system
to determine whether loss of astrocytic IGF1R affects their support for neurons. Astrocyte-neuron co-cultures
were developed using human primary astrocytes and differentiated Lund Human Mesencephalic Cells (LUHMES).
Neurite outgrowth assays, performed to measure astrocytic support for neurons, showed astrocytes provided
contact-mediated support for neurite outgrowth. Loss of IGF1R did not affect neurite outgrowth under control
conditions but when challenged with hydrogen peroxide IGF1R-impaired astrocytes were less able to protect
LUHMES. To determine how loss of IGF1R affects neuronal support MAB391-treated astrocytes were FACS sorted
from GFP-LUHMES and their transcriptomic profile was investigated using microarrays. Changes in transcripts
involved in astrocyte energy metabolism were identified, particularly NDUFA2 and NDUFB6, which are related
to complex I assembly. Loss of complex I activity in MAB391-treated astrocytes validated these findings. In con-
clusion, reduced IGF1 signaling in astrocytes impairs their support for neurons under conditions of stress and
this is associated with defects in the mitochondrial respiratory chain in astrocytes.  2018 The Authors. Published
by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).
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INTRODUCTION
The IGF1 signalling pathway involves a complex network
of intracellular interactions that are essential for cell
survival, growth and metabolism. IGF1 can enter the
brain by transcytosis across the blood brain barrier
(BBB) (Nishijima et al., 2010) or be produced centrally
by neurons and glia (Adamo et al., 1988, Cao et al.,
2011, Suh et al., 2013). IGF1 binding to homodimers of
IGF1R, or heterodimers comprising IGF1R and insulin
receptor (IR), induces a conformational change resulting
in autophosphorylation of the intracellular beta kinase
domain. This triggers downstream phosphorylation cas-
cades that result in activation of either protein kinase B
(Akt) or the extracellular-regulated kinase (Erk) pathway.
IGF1 is a more potent activator of the phosphoinositide-
3-kinase (PI3K)-Akt pathway, which typically regulates
metabolism and growth, and is a weak activator of the
Erk pathway, which has a more mitogenic role (Weng
et al., 2001, Clerk et al., 2006). In the brain, activation
of these divergent signalling pathways by IGF1 is impor-
tant in promoting neurogenesis, neurite outgrowth and
increasing synaptic coverage (Hansson et al., 1986,
Cheng et al., 2003).
During aging there is a gradual decline in growth
hormone and IGF1 which is associated with a decrease
in muscle mass and increase in fat deposition, as well
as other age-associated changes (Maggio et al., 2013).
Although reduction of IGF1 occurs as a consequence of
aging, there is extensive literature showing that reduced
signaling through this pathway extends lifespan but para-
doxically contributes to progression of age-related dis-
eases, such as cardiovascular and neurodegenerative
diseases. Impairment of IGF1 signaling has been demon-
strated in Alzheimer’s Disease (AD), particularly in neu-
rons. Altered IGF1 signaling has also been reported in
astrocytes in relation to Alzheimer’s type neuropathology
(Moloney et al., 2010, Simpson et al., 2011). In rodent
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astrocytes, IGF1 signaling is important for glucose
uptake, regulation of glutamate transport and protection
against oxidative stress in the brain (Hamai et al., 1999,
Suzuki et al., 2001, Genis et al., 2014). In mice, reduced
IGF1 levels in the serum and cerebral cortex causes neu-
rovascular uncoupling which is linked to loss of metabo-
tropic receptors and impaired release of vasodilator
mediators, such as arachidonic acid (Toth et al., 2015).
These studies suggest that astrocytic IGF1 signaling is
important for maintaining the support and protection of
neurons.
Previously, we developed an in vitro model of
impaired IGF1-signaling in human astrocytes to explore
how reduced input through this pathway affects function.
However no changes in phenotype were observed when
these astrocytes were grown in monoculture (Garwood
et al., 2015). Astrocytes mature functionally when grown
with neurons, as demonstrated by upregulation of
astrocyte-specific proteins such as glutamate trans-
porters (Swanson et al., 1997) and connexin 43/30
(Koulakoff et al., 2008) and changes in their transcrip-
tomic profile that are more representative of astrocytes
found in vivo (Goudriaan et al., 2014). In addition, IGF1
enhances neurite outgrowth only when astrocytes are
present in co-culture with neurons, suggesting that the
IGF1 signaling pathway in astrocytes provides support
for neurons (Ang et al., 1992). Thus a co-culture model
is more likely to replicate aspects of the systems biology
dysfunction present in AD brain.
We hypothesized that reduced IGF1 signaling in
astrocytes impairs their ability to provide support and
protection for neurons. We developed a human
astrocyte-neuron co-culture system and applied an
IGF1R monoclonal antibody to reduce the IGF1-receptor
in astrocytes. We show that, although this does not
impair neurite outgrowth under basal conditions, it
impairs astroglial-mediated neural support under stress
conditions. To further define how reduced IGF1R in
astrocytes may alter their ability to support neurons, we
used microarray gene expression analysis of astrocytes
separated from the co-cultures to explore alterations in
gene expression pathways.
EXPERIMENTAL PROCEDURES
Unless otherwise stated all materials were obtained from
Sigma Aldrich (Poole, Dorset, UK).
Primary human astrocytes, LUHMES, GFP LUHMES,
fibroblasts
Primary human astrocytes were obtained from ScienCell
Research Laboratories (Carlsbad, CA, US). Astrocytes
were expanded in Human Astrocyte Media (AM)
(ScienCell Research Laboratories) supplemented with
fetal bovine serum (FBS), penicillin streptomycin and
Astrocyte Growth Supplement (all ScienCell Research
Laboratories), prior to commencing experimental work
astrocytes were cultured in a 50:50 mix of F10:MEMa
media (Gibco) supplemented with 10% FBS (Biosera,
South America origin) and 1% penicillin streptomycin
(Lonza, Walkersville). To reduce IGF1R levels,
astrocytes were treated with 11 lg/ml of an IGF1R-
specific monoclonal antibody, MAB391 (R&D Systems,
MN, USA), for 24 h. This concentration is the known
EC50 value determined by R&D systems and was used
previously to reduce IGF1R (Garwood et al., 2015). After
24 h, cells were washed with 1  PBS and cells were cul-
tured for a further 72 h in fresh F10:MEMa media. An IgG
isotype control, MAB002 (R&D Systems, MN, USA) was
also included.
Lund human mesencephalic cells (LUHMES) are
conditionally-immortalized neuronal precursor cells that
can be differentiated over a 5-day period into post-
mitotic neurons (Scholz et al., 2011). Here they were used
as a neuronal readout of astrocyte support. LUHMES
were grown on cell culture flasks in proliferation medium
consisting of DMEM/F12 GlutaMAXTM supplement med-
ium (Gibco), N2 supplement (Gibco) and 40 ng/ml recom-
binant basic fibroblast growth factor (FGF) (Peprotech,
NJ, USA). When cells were 50–60% confluent they were
differentiated by replacing media with differentiation
media consisting of DMEM/F12 GlutaMAXTM supplement
medium, N2 supplement and 1 lg/ml tetracycline. After
two days, LUHMES were trypsinized and replated onto
the appropriate plates for a further 3 days before becom-
ing fully differentiated.
GFP LUHMES were generated by transducing non-
differentiated LUHMES with GFP-expressing lentiviral
particles (LV-GFP). GFP expression was under the
control of a PGK promoter. Low passage (p3-p5)
proliferating LUHMES, seeded at 1.5x106 cells per T75
flask, were transduced with LV-GFP for 24 h. Media
were replaced with fresh proliferation media and left for
a further 72 h before carrying out experiments.
Fibroblasts were obtained from NIGMS Human
Genetic Cell Repository at the Coriell Institute for
Medical Research (line GM09400) and were cultured in
Minimum essential medium supplemented with 10%
FBS (Labtech International, Heathfield, UK), 1% P/S,
1% MEM non-essential amino acids, 1% MEM vitamins,
1% sodium pyruvate and 60 lg/ml uridine. Fibroblasts
were used as a control to ensure that effects on neurite
outgrowth were specific to astrocytes.
Co-cultures
Astrocytes were co-cultured with LUHMES/GFP
LUHMES based on the strict differentiation protocol of
these cells. Initial neurite outgrowth assays were
performed to assess astrocyte support for LUHMES
under control conditions. Astrocytes were seeded onto
fibronectin (1 lg/ml)-coated 24-well plates (30,000
astrocytes/well) and differentiation media were added to
a separate flask of LUHMES. 2 days later LUHMES
were replated onto astrocytes (7500 cells/well) and the
co-cultures were then grown in differentiation media for
24 h. LUHMES were also cultured in astrocyte
conditioned media (ACM) and neuron-astrocyte
conditioned media (NACM) to determine whether
astrocytes support was contact mediated or was
through the release of soluble factors into the media.
The fibroblast-LUHMES co-culture system was set up in
a similar manner but with fibroblasts seeded onto
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fibronectin-coated plates at a slightly higher density
(50,000 fibroblasts/well).
For co-culture experiments with MAB391-treated
astrocytes the protocol was as follows: On day 1
astrocytes were seeded onto fibronectin-coated plates
and differentiation media were added to a separate flask
of GFP-LUHMES. On day 2, astrocytes were treated
with 11 lg/ml MAB391 or MAB002 for 24 hour. On day
3 GFP LUHMES were replated onto treated astrocytes,
and at this point the monoclonal antibody was removed.
Co-cultures were then maintained in differentiation
media for 72 h, after which co-cultures were treated with
50 lM H2O2 for 2 h.
Preparation of astrocyte lysates
Following treatments, medium was removed and cells
were washed with ice-cold PBS and lysed directly in
extra strong lysis buffer (100 mM Tris-HCl (pH 7.5),
0.5% (w/v) sodium dodecyl sulfate (SDS), 0.5% (w/v)
sodium deoxycholate, 1% (v/v) Triton X-100, 75 mM
sodium chloride (NaCl), 10 mM
ethylenediaminetetraacetric acid, 2 mM sodium
orthovanadate, 1.25 mM sodium fluoride, protease
inhibitor cocktail and PhosStop (both Roche, Basel,
Switzerland). Lysates were incubated on ice for 25 min,
sonicated and then centrifuged at 17 000 g (av) for
30 min at 4 C. A BCA protein assay kit (ThermoFisher
Scientific, Waltham, MA, USA) was used to determine
protein concentration.
SDS-PAGE and immunoblotting
40 lg of protein was loaded onto 8.5% (w/v) SDS-PAGE
gels and electrophoretically transferred to nitrocellulose
membrane (GE Healthcare, little Chalfont, Bucks, UK).
Membranes were blocked with Western Ezier Blocking
buffer (GenDEPOT, Barker, TX, UK) and then probed
with primary antibody, followed by horseradish
peroxidase (HRP)-conjugated secondary antibodies
(DAKO, Copenhagen, Denmark) and ECL (EZ-ECL
Biological Industries Israel). Proteins were detected
using the G:Box Chemi-XT CCD Gel imaging system
(Syngene, Cambridge, UK). Membranes were incubated
with the following primary antibodies: IGF1Rb (1/200;
Rabbit polyclonal sc-713, Santa Cruz BioTechnology
[SCBT], Dallas, Texas, US), Akt (1/1000; Rabbit
polyclonal 4685, CST), phospho Akt S473 (1/2000;
Rabbit monoclonal 4060, CST) and a-tubulin (1/200,
rabbit, ab18251, Abcam).
Immunocytochemistry
Cells were fixed in 4% (w/v) paraformaldehyde in PBS for
5 min at 37 C. Fixed cells were permeabilized (0.3% (v/v)
Triton X-100 in PBS) and then blocked with 3% (w/v)
bovine serum albumin before incubation with primary
antibodies. Co-cultures were first probed with Beta-III-
tubulin (1/1000; Chicken polyclonal, Millipore, 2424655)
followed by the appropriate species of Alexa-fluor-
conjugated secondary antibody (Life technologies). Co-
cultures were then incubated with primary antibodies
against GFAP (1/1000, Rabbit polyclonal, Abcam
Ab7260), Vimentin (1/250, Mouse monoclonal, Abcam,
Ab8978) and ALDH1L1 (1/100, Rabbit polyclonal,
Abcam, Ab79727) followed by incubation with the
appropriate species of secondary antibody. Nuclei were
stained with Hoechst 33342 (5 lg/ml bisbenzimide in
PBS). Astrocytes in monoculture were also incubated
with the primary antibodies detailed above. Images were
captured on a on a LV100ND microscope fitted with a
DS Ril Eclipse camera (Nikon, Tokyo, Japan).
MTT assays
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium
bromide) assays were performed to determine an
appropriate, sublethal, concentration of H2O2 to stress
the co-cultures. MTT (0.5 mg/mL) solution (110 lL) was
added to each well of a 12 well plate, and the plates
were incubated at 37 C with 5% CO2 for 3 h. Afterward,
1.1 ml of 20% SDS in 50% dimethylformamide was
added to each well, and the plates were incubated on a
mini orbital shaker SSM1 at 150 rpm (Bibby Scientific,
Stone, UK) for 3 h until formazan crystals were fully
dissolved. The OD of samples was determined by
measuring on a plate reader at 570 nm.
Neurite outgrowth assays
GFP LUHMES were co-cultured with astrocytes for 72 h
as described above, before fixation with 4% (w/v)
paraformaldehyde. Cells were permeabilized (0.3% (v/v)
Triton X-100 in PBS) and blocked with 3% (w/v) bovine
serum albumin. Cell nuclei were stained with Hoechst
33342 (5 lg/ml bisbenzimide in PBS) and mounted on
slides with fluorescent mounting medium
(DakoCytomation). Five images were captured of each
coverslip in a clockwise manner (3 coverslips per
experimental condition) on a LV100ND microscope fitted
with a DS Ril Eclipse camera (Nikon). Neurite length
was measured using an ImageJ plugin called Simple
Neurite Tracer. To assess astrocytic protection against
external stress, 72 h co-cultures were treated with
50 lM of H2O2 (sublethal concentration, data not
shown) for 2 h before fixing cells and assessing neurite
lengths.
Facs
To separate MAB391/IgG-treated astrocytes co-cultured
with GFP LUHMES cells were FACS sorted and
separated using the FACS ARIA cell sorter (BD
Biosciences). Cells were sorted for fluorescence and
forward scatter (FSC)/side scatter (SSC) size
dimensions. Cells with low fluorescence or cells with
overlapping SSC profiles were discarded in order to
achieve enriched populations of astrocytes and GFP
LUHMES. Cells were collected in Advanced MEM
media, centrifuged for 4 min at 400 g (av) and then
resuspended in TRIzol (Life Technologies). PCR
analysis was then performed to assess enrichment of
cell populations. RNA from FACS sorted cells was
isolated using Clean and Concentrator columns (Zymo,
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Irvine, CA, US). Total RNA was then incubated at 65 C
for 5 min and reverse transcribed at 42 C for 50 min in
a reaction mix containing qScriptTM cDNA SuperMix
(Quanta, Biosciences, Beverly, US). Amounts of NFL,
NeuN, GFAP and b-actin were detected using primers
listed in Table 1. PCR was performed in a G-storm
Thermal Cycler (G-storm, Somerset, UK) using the
following protocol: 94 C for 30 s, 67 C for 1 min, 72 C
for 30 s for 35 cycles. Samples were run on a 3%
agarose gel containing ethidium bromide at a final
concentration of 100 ng/ml. Gels were imaged using the
GENI UV light imaging system (Syngene).
Microarray analysis
The GeneChip WT PLUS reagent kit (Affymetrix) was
used to produce amplified, fragmented and labeled
sense-strand DNA targets from total RNA. In brief RNA
was reverse transcribed to produce single-stranded
cDNA, double-stranded cDNA was then synthesized to
produce a template for in vitro transcription, which
generated complementary RNA (cRNA). cRNA was
used to produce sense strand cDNA (ss-cDNA), which
was purified and treated with RNase to hydrolyze the
cRNA template. ss-cDNA was fragmented and labeled
with biotin before hybridizing to GeneChip Human
Gene ST (GST) Arrays using the GeneChip
Hybridisation, Wash and Stain Kit. All samples were
hybridized to arrays on the same day. Samples were
then injected and hybridized onto GeneChip Human
GST cartridges and incubated in a GeneChip
hybridization oven 645 at 16 rpm for 16 h at 45 C.
Hybridization, washing and staining was performed
using the Fluidics Station 400 and the Gene Chip
Operating System (GCOS). The GC3000 7G
scanner was used to scan gene chips and the
expression console software (Affymetrix) was used to
assess the quality of the data. Further analysis was
carried out using Qlucore Omics Explorer (Qlucore,
Lund, Sweden).
Data were normalized using the Robust Multi-array
Average (RMA) and a principal component analysis was
performed to determine the intensity distribution and
eliminate sample outliers.
MICROARRAY VALIDATION
PrimeTime qPCR Assays
Changes in transcript levels identified in the microarray
analysis were validated on FACS sorted control and
MAB391-treated astrocytes using mini qPCR assays
(Integrated DNA Technologies), listed in Table 2. Each
assay mix contained 60 ng of cDNA, 500 nM forward
and reverse primer, and a 250 nM probe resuspended
in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5),
2  Brilliant III qPCR Master mix and nuclease free
dH2O. Samples were run on a 2-step profile on a
Stratagene MX3000PTM Real Time Thermal Cycler
(Agilent Technologies Ltd) and incubated as follows: 10
minutes at 95 C then 40 cycles of 30 s at 95 C, 60 s at
60 C and 60 s at 72 C. GAPDH was amplified on each
plate to normalize expression levels of target genes
between different samples using the DDCt calculation
(ABI) and to assess assay reproducibility.
Functional assays
Nicotinamide adenine dinucleotide (NADH)-dependent
complex I activity was measured using the complex I
enzyme activity microplate assay kit (Abcam, ab109721,
Cambridge, UK) and performed according to
manufacturer’s protocol. The assay was performed on
both mono-cultured astrocytes and co-cultures grown on
fibronectin-coated 10-cm dishes and 250 lg of protein
was needed per well of the microplate. Extracellular
lactate in the co-culture media was measured using the
lactate assay kit (Abnova, KA0833, Taiwan) and
performed according to the manufacturer’s protocol.
Statistical analysis
Data were analyzed using either student’s unpaired t-test
or a one-way analysis of variance with Tukey’s post-hoc
analysis. Prior to performing t-tests data were checked
for normality using the D’Agostino and Pearson omnibus
normality test (Graphpad Prism 5.0 Software, Graphpad
Software Inc., La Jolla, CA, USA).
The Integrated Molecular Pathways Level Analysis
(IMPaLA) enrichment tool was used to generate
enriched biological pathways from the official gene
symbols imported from the microarray.
RESULTS
Development of a human astrocyte-neuron co-culture
system
In order to assess whether reduced IGF1R levels in
astrocytes affected their function a human astrocyte-
neuron co-culture system was developed, with LUHMES
used as a neuronal readout of astrocyte support.
LUHMES develop extensive neurites, form synapses
and display spontaneous electrical activity (Scholz et al.,
2011). They also express and spontaneously process
the amyloid precursor protein and so have been used
as a model system for AD (Scholz et al., 2013). LUHMES
were differentiated for two days before replating on top of
Table 1. PCR primer details
Primer type Forward sequence Reverse Sequence
b-actin TCCCCCAACTTGAGATGTATGAAG AACTGGTCTCAAGTCAGTGTACAGG
GFAP GCAGAAGCTCCAGGATGAAAC TCCACATGGACCTGCTGTC
NFL GGCTCTCAGTGTATTGGCTTCTGT AACCCAGGTCTAGTAAGCAGAAAT
NeuN ACGATCGTAGAGGACGGAA AATTCAGGCCCGTAGACTGC
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a confluent bed of primary human astrocytes (Fig. 1 sche-
matic). After 72 h in co-culture, astrocytes expressed a
range of astrocytic markers including vimentin, aldehyde
dehydrogenase 1 family member L1 (ALDH1L1) and glial
fibrillary acidic protein (GFAP) (Fig. 1 A-C) while neurons,
immunolabeled with b-III-tubulin, extended processes that
appeared to localize on top of astrocytes (Fig. 1 A,B). Co-
cultured astrocytes displayed a range of morphologies
including flat polygonal cells as well as stellate, process-
bearing cells.
Table 2. qPCR primer/probe sequence
Gene PrimeTime  Assay ID Ref Seq Region Primer Sequence
NDUFA2 Hs.PT.58.38915668 NR_033697 Exon 2-3 50-AGCACTGAAGTTGTTCAAAGG-30
50-GACTTCATTGAGAAACGCTACG-30
NDUFB6 Hs.PT.58.20921068.g NM_002493 Exon1-1 50-CATCGCCTTCTCAGCTCTC-30
50-CTAGTCCGTAGTTCGAGGGT-30
TP11 Hs.PT.58.40028166.g NM_001159287 Exon 3-4 50-TCCGCAGTCTTTGATCATGC-30
50-CTACTGCCTATATCGACTTCGC-30
ENO2 Hs.PT.58.578449 NM_001975 Exon7-8 50-TTCCTTCACCAGCTCCAAG-30
50-CAGAGGTCTACCATACACTCAAG-30
GAPDH Hs.PT.39a.22214836 NM_002046 Exon 2-3 50-TGTAGTTGAGGTCAATGAAGGG-30
50-ACATCGCTCAGACACCATG-30
Fig. 1. Co-cultured human ScienCell astrocytes and LUHMES. Schematic depicts the time line for setting up the co-culture system. On day 0
LUHMES were differentiated by addition of tetracycline to the culture medium. Two days later differentiating LUHMES were plated onto control
astrocytes. LUHMES and astrocytes were then co-cultured for 72 h prior to fixation, phase contrast image of co-cultured cells is shown. (A-C).
Immunocytochemistry of co-cultured LUHMES and astrocytes after 72 h of co-culture. LUHMES were immunolabeled with b-III-tubulin (green),
nuclei with Hoechst (blue) and astrocytes were labeled with (A) vimentin, (B) ALDH1L1 and (C) GFAP (all in red). (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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Astrocytic support for neurons is contact-dependent
Neurite outgrowth is an important morphological
phenotype of neurons and correlates well with neuronal
health (Radio and Mundy, 2008, Harrill et al., 2013) We
show using this novel co-culture system that astrocytes
support neuronal health as demonstrated by a significant
increase in neurite length in the presence of astrocytes
(Fig. 2A, B, p< 0.0001). To determine whether this was
mediated by soluble factors released by the astrocytes,
or due to specific contacts made in co-culture, neurite
length was measured in LUHMES cultured in astrocyte
conditioned media (ACM), and in co-cultures. To improve
the detection of neurites on a background of astrocytes,
LUHMES were transduced with LV-GFP. After 24 h there
was a significant increase in neurite outgrowth in co-
cultured GFP LUHMES (Fig. 2A, p< 0.0001) but not in
LUHMES cultured in ACM. To account for the fact that
soluble factors released by astrocytes may change when
co-cultured with neurons (LUHMES), media was collected
from a 24-h co-culture (neuron-astrocyte conditioned
media, NACM) and incubated on GFP LUHMES for 24 h
prior to measurement of neurite length. Again a significant
increase in neurite length was observed only when GFP
LUHMES were co-cultured with astrocytes (Fig. 2B,
Fig. 2. Neurite outgrowth is enhanced by direct contact with astrocytes. LUHMES were cultured with astrocytes, in astrocyte conditioned media
(ACM) or in neuron-astrocyte conditioned media (NACM) to determine if enhanced neurite growth was contact-mediated or due to a soluble factor
released by astrocytes. (A) Representative images of GFP LUHMES grown in monoculture, in astrocyte-conditioned media (ACM) or in co-culture
for 24 h. (B) Representative images of GFP LUHMES grown in monoculture, in neuron-astrocyte conditioned media (NACM) or in co-culture for
24 h. (C) GFP LUHMES were also co-cultured with fibroblasts to confirm enhanced neurite outgrowth was an astrocyte-specific effect Bar charts
shows quantification of neurite lengths, data are mean + SEM (n= 3, 3 replicates/experiment, One-way ANOVA with post-hoc analysis,
***p< 0.001, ****= p< 0.0001).
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p< 0.0001) verifying that the enhancement in neurite
outgrowth is contact-mediated. This effect on neurite
outgrowth is specific to astrocytes since GFP-LUHMES
co-cultured with fibroblasts show no increase in neurite
outgrowth (Fig. 2C).
Loss of IGF1R in astrocytes impairs neuronal support
under conditions of stress.
An IGF1R-specific monoclonal antibody, MAB391, was
used to reduce IGF1R levels in human ScienCell
astrocytes (Garwood et al., 2015). MAB391 reduces
IGF1R receptor levels by binding to and inducing degra-
dation of the receptor (Hailey et al., 2002, Garwood
et al., 2015). Astrocytes were grown in monoculture, trea-
ted with MAB391 for 24 h, washed and then cultured for a
further 72 h. Immunoblots showed that treatment with
MAB391 caused a significant reduction in IGF1R levels
(Fig. 3A, p< 0.01). There was a significant increase in
pAkt (s473) at this timepoint (96 h after MAB391 treat-
ment) (Fig. 3A, p< 0.05).
Using neurite outgrowth as a measure of astrocyte
support, we investigated the effect of reduced astrocytic
IGF1R levels in co-culture. Astrocytes were pre-treated
with MAB391 for 24 h, washed and incubated with GFP
LUHMES for 72 h before neurite length was measured.
Astrocytes significantly enhanced neurite outgrowth after
72 h in co-culture (Fig. 3B, p< 0.0001), and this was
not affected by loss of IGF1R.
Astrocytes can protect neurons from oxidative stress,
and experiments using rodent astrocytes suggest that
IGF1 signaling plays an important role in this process
(Genis et al., 2014). Since oxidative stress increases in
the aging brain, and is associated with various neurode-
generative diseases, we assessed whether astrocytes
could support neurons under conditions of oxidative
stress, and whether loss of IGF1R abrogated the protec-
tion offered to neurons. GFP LUHMES in monoculture
showed a significant reduction in neurite length after treat-
ment with 50 lM hydrogen peroxide (H2O2) for 2 h (Fig. 4.
p< 0.001). This reduction in neurite length was prevented
when GFP LUHMES were co-cultured with control
Fig. 3. Loss of astrocytic IGF1R does not impair support for neurite outgrowth. (A) Western blots of cell lysates from primary astrocytes. Astrocytes
were treated for 24 h with MAB391 to induce IGF1R loss and following a media exchange cultured for a further 72 h. Representative western blots
probed with antibodies against IGF1Rb and pAkt (s473) are shown. Bar charts show quantification of IGF1Rb relative to a-tubulin and pAkt (s473)
relative to total Akt. Data are mean + SEM (n= 3, 3 replicates/experiment, unpaired student’s t-test * = p< 0.05 and ** = p< 0.01). (B) GFP
LUHMES were cultured alone or with control, IgG- or MAB391-treated astrocytes for 72 h and neurite outgrowth was assessed (scale bar
represents 50 lm). Representative images of GFP LUHMES are shown, bar chart shows quantification of neurite lengths (measured in pixels). Data
are mean + SEM (n= 3, 3 replicates/experiment, One-way ANOVA with post-hoc analysis, **** = p< 0.0001).
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astrocytes. However, when GFP LUHMES were co-
cultured with MAB391-treated astrocytes this protection
was lost, and a significant reduction in neurite length
was observed following H2O2 treatment (Fig. 4,
p< 0.0001). Astrocytes were also pre-treated with an
IgG isotype control, which does not reduce IGF1R levels
(Garwood et al., 2015). Treating astrocytes with the IgG
isotype control did not affect support for neurite outgrowth
under control or stress conditions, suggesting that it is
specifically the loss of IGF1R that leads to impaired astro-
cyte function.
Loss of IGF1R affects astrocyte energy metabolism
Microarray gene expression analysis was performed on
FACS sorted MAB391-treated astrocytes separated from
co-cultures to assess the underlying transcriptomic
changes that may contribute to reduced neuronal support
(Fig. 5A, B). A DNA gel was used to assess the
separation of astrocytes and LUHMES by checking the
expression of astrocyte and neuron-specific transcripts.
GFAP expression was elevated in the FACS-sorted
astrocytes with minimal expression in FACS-sorted
LUHMES, indicating little contamination of the neuronal
population with astrocytes. Low levels of NeuN in FACS-
sorted astrocytes indicated that astrocytes had been
enriched from co-culture during the FACS sorting
process (Fig. 5C).
The transcriptomic profile of MAB391-treated
astrocytes was determined using Affymetrix GeneChip
Whole Transcript Arrays. The arrays identified 2815
differentially expressed genes in MAB391-treated
astrocytes compared to untreated astrocytes, with 1520
transcripts downregulated and 1295 transcripts
upregulated (at fold change [FC] = 1.2 and p< 0.05).
To categorize the biological pathway alterations following
MAB391 treatment, pathway enrichment analysis was
performed in IMPALA (Tables 3 and 4). Overall, the
analysis suggested impaired astrocyte energy
metabolism, and more specifically dysregulation of the
mitochondrial electron transport chain and glycolysis.
Tables 5 and 6 provide lists of genes related to
mitochondrial function and glycolysis that were altered in
MAB391-treated astrocytes.
Since astrocytes can compensate for impaired
mitochondrial respiration by switching to glycolysis
Fig. 4. IGF1R impaired astrocytes are less neuroprotective. GFP LUHMES were cultured alone or with control, IgG- or MAB391-treated astrocytes
for 72 h. After 72 h co-cultures were treated with 50 lM H2O2 for 2 h. Representative images of GFP LUHMES are shown, scale bar represents
50 lm. Bar charts show quantification of neurite lengths from these images (measured in pixels). Data are mean + SEM (n= 3, 3
replicates/experiment, unpaired student’s t-test, ***= p< 0.001 and ****= p< 0.0001).
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(Almeida et al., 2001; Bolanos et al., 2008) we assessed
whether there was a switch in energy metabolism in IGF1-
impaired astrocytes by performing qRT-PCR and func-
tional analysis. Expression of two of the most differentially
expressed genes in the electron transport chain, NADH
ubiquinone oxidoreductase subunit 2 (NDUFA2,
p value = 0.003 and FC= 0.71) and B6 (NDUFB6,
p value = 0.004 and FC= 0.53); and in the glycolysis
pathway, triosephosphate iso-
merase (TPI1, p value = 0.03 and
FC = 1.59) and enolase 2
(ENO2, p value = 0.01 and
FC = 1.46) were assessed in inde-
pendent FACS-sorted untreated,
IgG-treated and MAB391-treated
astrocytes. The electron-transport-
related transcript, NDUFA2 was
downregulated with MAB391 treat-
ment, which is consistent with the
array data (Fig. 6A). NDUFB6
showed no significant reduction
compared to control, however
treatment with IgG alone cause a
significant increase which might
therefore mask any effect of IGF1R
loss on NDUFB6 (Fig. 6A).
Changes in the glycolytic tran-
scripts were not clear since TPI1
was significantly downregulated
(opposite to the array) and there
was an increase in ENO2 transcript
levels in MAB391-treated astro-
cytes, which may be an IgG-
specific effect (data not shown).
To assess this putative
metabolic switch functionally, a
complex I assay and a lactate
assay were performed. Complex I
activity was assessed since the
expression of five genes involved
in complex I assembly (NDUFA1,
NDUFA2, NDUFB3, NDUFB6 and
NDUFAB1) were downregulated
following MAB391 treatment.
Measurements of complex I
activity were initially performed in
co-culture, since FACS sorting of
astrocytes did not generate
sufficient protein to be used in the
assay. The activity of complex I
was significantly reduced following
MAB391 treatment (Fig. 6B)
compared to IgG isotype-treated
control (p< 0.05) and untreated
co-cultures (p< 0.01). Complex 1
activity was also assessed in
mono-cultured astrocytes to
confirm that the reduction in
complex 1 activity could
specifically be attributed to
astrocytes, a significant
reduction in complex 1 activity was observed in MAB391-
treated astrocytes compared to both untreated control
(p< 0.01) and IgG-treated control (p< 0.01) (Fig. 6C).
Extracellular lactate levels did not change following
IGF1R loss (data not shown). These results indicate that
loss of IGF1R in human astrocytes in co-culture induces
a defect in the first step in the mitochondrial electron
transport chain.
Fig. 5. FACS sorting of astrocytes from GFP LUHMES. (A) Astrocytes were treated with or without
MAB391 for 24 h, washed and co-cultured with GFP LUHMES for 72 h. Astrocytes and LUHMES were
FACS sorted and individually collected in Trizol for RNA extraction. RNA isolated from astrocytes was
then subjected to Microarray gene expression analysis. (B) FACS was carried out on astrocytes, GFP
LUHMES and co-cultures. Cells were gated according to SSC (side scatter) profile and fluorescence
(Blue 530-30-A). (C) DNA gel shows enrichment of astrocytes following FACS sorting of co-cultures;
GFAP was used as an astrocytic marker, NeuN as a neuronal marker and b-actin as a loading control.
The DNA gel was loaded as follows: astrocyte monoculture, undifferentiated LUHMES monoculture,
FACS-sorted astrocytes and FACS-sorted differentiated LUHMES.
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DISCUSSION
Astrocytes play an important role in maintaining brain
health by supporting and protecting neuronal function.
Reduced insulin/IGF1 signaling has been demonstrated
in neurons in AD and more recently this has been
shown in astrocytes (Simpson et al., 2011). Here we show
that IGF1R-impaired astrocytes are less able to support
and preserve neurite outgrowth following oxidative stress
using a novel human astrocyte neuron co-culture system.
Microarray analysis indicated that this defect is associ-
ated with altered mitochondrial function, particularly
impairments in complex I activity.
To assess the impact of reduced IGF1 signaling in
human astrocytes we developed a novel co-culture
system using human primary astrocytes and
conditionally immortalized LUHMES which can be
differentiated into post-mitotic neurons (Scholz et al.,
2011). Here we show that human primary astrocytes
enhance neurite outgrowth, and that this enhancement
is contact dependent and is specific to astrocytes.
Treatment with the monoclonal antibody MAB391
resulted in persistent loss of IGF1R, although this is not
reflected downstream through Akt. In our previous paper
we reported a decrease in pAkt S473 24 h after
treatment (Garwood et al., 2015), but here we see an
increase 96 h after IGF1R reduction. This likely reflects
overcompensation through other receptors which activate
Akt either directly or indirectly, these include G-protein-
coupled receptors, interleukin receptors, interferon recep-
tors and growth hormone receptors (Murga et al., 1998,
Wymann et al., 2003, New et al., 2007). It also highlights
that cell signaling pathways and their interactions are not
linear and are highly integrated networks.
Loss of IGF1R did not affect the ability of astrocytes to
support neurite outgrowth under normal conditions.
However, when co-cultures were exposed to H2O2,
there was a significant reduction in neurite length. This
is consistent with experiments performed in rodent
astrocytes, where IGF1 signaling is important in
protecting against reactive oxygen species (ROS)
formation and in maintaining support to neurons during
oxidative stress (Genis et al., 2014). To explore the
underlying mechanisms responsible for this, the transcrip-
tome of MAB391-treated astrocytes isolated from
co-culture was investigated using microarray gene
expression analysis. This identified a number of biological
pathways that may be altered in MAB391-treated astro-
cytes, including defects in pathways related to astrocyte
energy metabolism, and specifically alterations in
complex 1 of the mitochondrial respiratory chain.
The five complex I-related transcripts reduced in the
array are all found in the ‘‘P” module of complex I,
Table 3. IMPALA Enrichment Pathway analysis for 1520 downregulated transcripts in MAB391-treated astrocytes compared to untreated astrocytes
with FC  1.2 and p< 0.05
Pathway Pathway
source
Number of DE genes in the
pathway
p value
Parkinson’s Disease KEGG 12 0.0000335
Ubiquitin mediated proteolysis KEGG 11 0.0000864
TCA cycle and respiratory electron transport Reactome 11 0.0002250
Electron transport chain Wikipathways 9 0.0002670
Respiratory electron transport-ATP synthesis by chemiosmotic coupling Reactome 9 0.0003550
Respiratory electron transport Reactome 8 0.0003820
Oxidative phosphorylation KEGG 8 0.0059300
Huntington’s Disease KEGG 10 0.0059700
Mitochondrial electron transport chain SMPDB 3 0.0065600
Antigen processing Reactome 9 0.0065900
Table 4. IMPALA Enrichment Pathway analysis for 1295 upregulated transcripts in MAB391-treated astrocytes compared to untreated astrocytes with
FC  1.2 and p< 0.05
Pathway Pathway source Number of DE genes in the pathway p value
Small Ligand GPCRs Wikipathways 5 0.0000268
Glycolysis HumanCyc 5 0.0003840
Gluconeogenesis HumanCyc 5 0.0004650
Glycolysis Reactome 5 0.0006660
Gluconeogenesis Reactome 5 0.0012600
Lysosphingolipid and LPA receptors Reactome 3 0.0012700
Parkin-ubiquitin proteasomal system pathway Wikipathways 7 0.0024900
Glycine, serine and threonine metabolism KEGG 5 0.0031000
Rapoport-Luebering glycolytic shunt HumanCyc 2 0.0038500
Catecholamine biosynthesis HumanCyc 2 0.0038500
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which is responsible for anchoring the multi-subunit
complex and pumping protons across the inner
mitochondrial membrane. Two of these complex I
transcripts (NDUFA2 and NDUFB6) were subsequently
validated by qPCR. Loss of these specific transcripts
may prevent proper assembly of complex I (Yadava
et al., 2002, Hoefs et al., 2008, Mimaki et al., 2012) and
thus limit its activity. This is supported by the functional
assays performed here which showed a loss of NAD+-
dependent complex I activity in astrocytes. Part of the
defect in complex I may be attributed to treatment with
the monoclonal antibody as there was a significant reduc-
tion in complex I activity following IgG treatment, however
there was a further significant reduction after MAB391
treatment. IgG is one of the components in the blood that
extravasates from vessels with impairment of the blood
brain barrier during neurodegeneration (Paul et al.,
2013) and so this result may highlight another mechanism
underpinning altered mitochondrial respiration in astro-
cytes during neurodegeneration. In addition to changes
in complex I transcripts, 33 other genes involved in mito-
chondrial stability and function were downregulated fol-
lowing MAB391 treatment. These findings suggest an
overall defect in mitochondrial function in these astrocytes
which are not restricted to loss of complex I activity and
suggests that a loss of IGF1R results in reduced mito-
chondrial respiration. This differs from the IR which also
signals through pAkt but has actions distinct from IGF1
(Werner and LeRoith, 2014). Loss of this receptor is
reported to result in an increase in mitochondrial respira-
tion however, the loss of IR also resulted in reduced glu-
cose uptake and glycolytic rate (Garcia-Caceres et al.,
Table 5. Transcripts involved in mitochondrial function that are dysregulated in IGF1R impaired astrocytes. Fold change (FC) and p-values are also
shown
Gene Symbol Gene Name FC p-Value
ATP5C1 ATP synthase, H + transporting, mitochondrial F1 complex, gamma polypeptide 1 0.72 5.0E-02
NDUFA1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 0.65 3.0E-02
NDUFA2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 0.71 4.0E-03
NDUFB3 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 0.73 3.0E-02
NDUFB6 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 0.53 3.0E-03
NDUFAB1 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex, 1 0.77 1.0E-03
YME1L1 YME1-like 1 0.58 1.0E-03
ARG2 Arginase, type II 0.76 4.0E-03
ETFA Electron-transfer-flavoprotein, alpha polypeptide 0.71 4.0E-03
GOLPH3 Golgi phosphoprotein 3 0.82 3.0E-02
MMADHC Methylmalonic aciduria 0.71 3.0E-04
MGST1 Microsomal glutathione S-transferase 1 0.77 2.0E-02
MRPL3 Mitochondrial ribosomal protein L3 0.76 2.0E-02
MRPL32 Mitochondrial ribosomal protein L32 0.80 2.0E-02
MRPL46 Mitochondrial ribosomal protein L46 0.64 3.0E-02
MRPS18A Mitochondrial ribosomal protein S18A 0.82 3.0E-02
NLN Neurolysin 0.69 2.0E-02
NMNAT3 Nicotinamide nucleotide adenylyltransferase 3 0.77 3.0E-02
OGDHL Oxoglutarate dehydrogenase-like 0.82 2.0E-02
PMPCB Peptidase (mitochondrial processing) beta 0.75 4.0E-02
PRDX3 Peroxiredoxin 3 0.72 2.0E-03
PPP2R2B Protein phosphatase 2 (formerly 2A) regulatory subunit B, beta isoform 0.61 2.0E-03
PDK3 Pyruvate dehydrogenase kinase, isozyme 3 0.58 5.0E-02
ROMO1 Reactive oxygen species modulator 1 0.61 1.0E-04
SFXN4 Sideroflexin 4 0.80 2.0E-02
UQCRB Ubiquinol-cytochrome C reductase binding protein 0.66 6.0E-03
SSBP1 Single-stranded DNA binding protein 1 0.68 5.0E-02
SLC25A14 Solute carrier 25 (mitochondrial carrier, brain) 0.79 2.0E-02
SDHB Succinate dehydrogenase complex, subunit B 0.76 1.0E-02
SUCLA2 Succinate-coA ligase, ADP forming, beta subunit 0.76 4.0E-02
TXNDC12 Thioredoxin domain containing 12 0.77 6.0E-03
TIMM9 Translocase of inner mitochondrial membrane 9 0.76 3.0E-02
TOMM6 Translocase of outer mitochondrial membrane 6 0.69 1.0E-02
Table 6. Transcripts involved in glycolysis that are dysregulated in
IGF1R impaired astrocytes. Fold change (FC) and p-values are also
shown
Gene symbol Gene Name FC p-Value
ENO1 Enolase 1 1.23 0.0400
ENO1-AS Enolase 1-alpha 1.85 0.0030
ENO2 Enolase 2 1.46 0.0100
PDK3 Pyruvate dehydrogenase
kinase 3
0.58 0.0500
PGAM2 Phosphoglycerate mutase 2 1.42 0.0006
SLC16A3 Solute Carrier Family 16,
Member 3
2.04 0.0200
TPI1 Triosephosphate isomerase 1 1.59 0.0300
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2016) and the increase in mitochondrial respiration might
therefore be a compensatory mechanism.
Astrocytes generate most of their ATP through
mitochondrial respiration. When this process is inhibited
astrocytes upregulate glycolysis to maintain levels of
ATP and supply lactate to neurons as an energy
substrate for oxidative phosphorylation (Pellerin and
Magistretti, 1994; Marcillac et al., 2011; Brix et al.,
2012; Kasparov, 2016; Machler et al., 2016). However
there is also evidence to suggest that neuronal oxidative
phosphorylation is not dependent on lactate supplied by
astrocytes (Hall et al., 2012). Although changes in expres-
sion of the glycolytic genes TPI1 and ENO2 were identi-
fied in the array these did not validate in our
experiments and there was no obvious effect on extracel-
lular levels of lactate following MAB391 treatment.
Several mechanisms may contribute to complex I
dysregulation following IGF1R loss. Loss of IGF1R has
been associated with increased GLUT1 expression and
glucose uptake in rodent astrocytes (Hernandez-Garzon
et al., 2016). If this process is not
properly regulated more glycolyti-
cally produced NADH will ‘over-
drive’ complex I, resulting in
increased leakage of electrons
and superoxide formation (Pryde
and Hirst, 2011). Increased ROS
generation can cause oxidative
damage to mitochondrial proteins
and DNA, including those related
to complex I. Loss of astrocyte
complex I activity may be the
underlying mechanism responsible
for reduced protection of neurons
against H2O2. Inhibition of mito-
chondrial activity with fluorocitrate,
causes reduced ATP production
and changes in mitochondrial
membrane potential without affect-
ing astrocyte viability, however
when these cells are further chal-
lenged with glutamate astrocyte
viability and neuronal survival is
compromised (Voloboueva et al.,
2007). This is similar to the findings
presented here which suggests
that astrocytes fail to cope with an
additional challenge when mito-
chondrial function is compromised
by reduced signaling through
IGF1R. Genis et al. (2014) have
also previously reported that the
IGF1 signaling pathway is impor-
tant in preventing ROS production
and supporting neuronal survival
when challenged with oxidative
stress in rodent astrocytes.
CONCLUSION
Impairments in astrocytic IGF1
signaling affects their ability to protect neurons from
oxidative stress, and is associated with dysregulation of
energy-related metabolic pathways in astrocytes.
Preserving or restoring IGF1 signaling in astrocytes to
optimum levels might be an important translational goal
to maintaining mitochondrial health, and hence neuronal
support, during aging and stress, and this is relevant to
a range of age-related neurodegenerative disorders.
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